{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:19:21Z","timestamp":1788967161148,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.mayocp.2017.08.019","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T11:15:23Z","timestamp":1512126923000},"page":"1842-1849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"title":["Genitourinary Syndrome of Menopause: Management Strategies for the Clinician"],"prefix":"10.1016","volume":"92","author":[{"given":"Stephanie S.","family":"Faubion","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekta","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.mayocp.2017.08.019_bib1","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/GME.0b013e3182a122c2","article-title":"Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society","volume":"20","year":"2013","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.mayocp.2017.08.019_bib2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.maturitas.2014.07.013","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society","volume":"79","author":"Portman","year":"2014","journal-title":"Maturitas"},{"issue":"7","key":"10.1016\/j.mayocp.2017.08.019_bib3","first-page":"1790","article-title":"Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey","volume":"10","author":"Kingsberg","year":"2013","journal-title":"J\u00a0Sex Med"},{"issue":"3","key":"10.1016\/j.mayocp.2017.08.019_bib4","first-page":"413","article-title":"The Women's EMPOWER survey: identifying women's perceptions on vulvar and vaginal atrophy and its treatment","volume":"14","author":"Kingsberg","year":"2017","journal-title":"J\u00a0Sex Med"},{"issue":"2","key":"10.1016\/j.mayocp.2017.08.019_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/GME.0b013e318295236f","article-title":"Clarifying Vaginal Atrophy's Impact on Sex and Relationships (CLOSER) survey: emotional and physical impact of vaginal discomfort on North American postmenopausal women and their partners","volume":"21","author":"Simon","year":"2014","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.mayocp.2017.08.019_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/13697137.2015.1124259","article-title":"Treating vulvovaginal atrophy\/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?","volume":"19","author":"Edwards","year":"2016","journal-title":"Climacteric"},{"issue":"4","key":"10.1016\/j.mayocp.2017.08.019_bib7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.fertnstert.2013.12.024","article-title":"In\u00a0vitro effects of coital lubricants and synthetic and natural oils on sperm motility","volume":"101","author":"Sandhu","year":"2014","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.mayocp.2017.08.019_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0010-7824(89)90018-8","article-title":"Mineral oil lubricants cause rapid deterioration of latex condoms","volume":"39","author":"Voeller","year":"1989","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.mayocp.2017.08.019_bib9","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/AOG.0b013e31828786f8","article-title":"Intravaginal practices and risk of bacterial vaginosis and candidiasis infection among a cohort of women in the United States","volume":"121","author":"Brown","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.mayocp.2017.08.019_bib10","first-page":"1575","article-title":"Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial","volume":"10","author":"Chen","year":"2013","journal-title":"J\u00a0Sex Med"},{"issue":"4","key":"10.1016\/j.mayocp.2017.08.019_bib11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/GME.0000000000000786","article-title":"The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy","volume":"24","author":"Constantine","year":"2017","journal-title":"Menopause"},{"key":"10.1016\/j.mayocp.2017.08.019_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.maturitas.2017.02.008","article-title":"A\u00a0vaginal estradiol softgel capsule, TX-004HR, has negligible to very low systemic absorption of estradiol: efficacy and pharmacokinetic data review","volume":"99","author":"Simon","year":"2017","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.mayocp.2017.08.019_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/13697137.2015.1136926","article-title":"Pharmacokinetic studies of solubilized estradiol given vaginally in a novel softgel capsule","volume":"19","author":"Pickar","year":"2016","journal-title":"Climacteric"},{"issue":"7","key":"10.1016\/j.mayocp.2017.08.019_bib14","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/GME.0000000000000921","article-title":"The 2017 hormone therapy position statement of The North American Menopause Society","volume":"24","year":"2017","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.mayocp.2017.08.019_bib15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/annonc\/mdj127","article-title":"Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors","volume":"17","author":"Kendall","year":"2006","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2017.08.019_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1200\/JOP.2011.000352","article-title":"Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptor modulator","volume":"8","author":"Wills","year":"2012","journal-title":"J\u00a0Oncol Pract"},{"issue":"3","key":"10.1016\/j.mayocp.2017.08.019_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/GME.0b013e31829755ed","article-title":"Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy","volume":"21","author":"Pinkerton","year":"2014","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.mayocp.2017.08.019_bib18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/gme.0b013e318279ba64","article-title":"Ospemifene Study Group. Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy","volume":"20","author":"Portman","year":"2013","journal-title":"Menopause"},{"issue":"10","key":"10.1016\/j.mayocp.2017.08.019_bib19","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1177\/1933719113497290","article-title":"Profile of ospemifene in the breast","volume":"20","author":"Berga","year":"2013","journal-title":"Reprod Sci"},{"issue":"1","key":"10.1016\/j.mayocp.2017.08.019_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/gme.0b013e318223e82a","article-title":"Ospemifene and 4-hydroxyospemifene effectively prevent and treat breast cancer in the MTag.Tg transgenic mouse model","volume":"19","author":"Burich","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.mayocp.2017.08.019_bib21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jsbmb.2013.12.011","article-title":"Use of SERMs for treatment in postmenopausal women","volume":"142","author":"Pinkerton","year":"2014","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"2","key":"10.1016\/j.mayocp.2017.08.019_bib22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/gme.0b013e3181b7c65f","article-title":"A\u00a0randomized, placebo- and active-controlled trial of bazedoxifene\/conjugated estrogens for treatment of moderate to severe vulvar\/vaginal atrophy in postmenopausal women","volume":"17","author":"Kagan","year":"2010","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.mayocp.2017.08.019_bib23","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.fertnstert.2009.03.113","article-title":"Evaluation of bazedoxifene\/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile","volume":"92","author":"Lobo","year":"2009","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.mayocp.2017.08.019_bib24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/13697137.2010.535226","article-title":"Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia","volume":"14","author":"Labrie","year":"2011","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.mayocp.2017.08.019_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/GME.0000000000000571","article-title":"Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause","volume":"23","author":"Labrie","year":"2016","journal-title":"Menopause"},{"issue":"12","key":"10.1016\/j.mayocp.2017.08.019_bib26","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/GME.0000000000000470","article-title":"Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women","volume":"22","author":"Portman","year":"2015","journal-title":"Menopause"},{"issue":"5","key":"10.1016\/j.mayocp.2017.08.019_bib27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00192-017-3282-y","article-title":"Laser therapy as a treatment modality for genitourinary syndrome of menopause: a critical appraisal of evidence","volume":"28","author":"Arunkalaivanan","year":"2017","journal-title":"Int Urogynecol J"},{"issue":"6","key":"10.1016\/j.mayocp.2017.08.019_bib29","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/GCO.0000000000000230","article-title":"The use of pulsed CO2 lasers for the treatment of vulvovaginal atrophy","volume":"27","author":"Stefano","year":"2015","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.mayocp.2017.08.019_bib30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/13697137.2014.899347","article-title":"A\u00a012-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study","volume":"17","author":"Salvatore","year":"2014","journal-title":"Climacteric"},{"issue":"2","key":"10.1016\/j.mayocp.2017.08.019_bib31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/lsm.22569","article-title":"Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause","volume":"49","author":"Gaspar","year":"2017","journal-title":"Lasers Surg Med"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2017.08.019_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/13697137.2015.1071608","article-title":"Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence","volume":"18","author":"Gambacciani","year":"2015","journal-title":"Climacteric"},{"issue":"2","key":"10.1016\/j.mayocp.2017.08.019_bib33","first-page":"238","article-title":"Internet-based guided self-help for vaginal penetration difficulties: results of a randomized controlled pilot trial","volume":"14","author":"Zarski","year":"2017","journal-title":"J\u00a0Sex Med"},{"issue":"2","key":"10.1016\/j.mayocp.2017.08.019_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.mayocp.2011.09.004","article-title":"Recognition and management of nonrelaxing pelvic floor dysfunction","volume":"87","author":"Faubion","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"30","key":"10.1016\/j.mayocp.2017.08.019_bib35","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1200\/JCO.2014.60.7366","article-title":"A\u00a0practical solution for dyspareunia in breast cancer survivors: a randomized controlled trial","volume":"33","author":"Goetsch","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.mayocp.2017.08.019_bib37","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/GME.0000000000000465","article-title":"One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy","volume":"22","author":"Portman","year":"2015","journal-title":"Menopause"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619617306390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619617306390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T05:42:56Z","timestamp":1635486176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619617306390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0025619617306390"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2017.08.019","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genitourinary Syndrome of Menopause: Management Strategies for the Clinician","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2017.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}